However, despite the Fmr1 KO mouse represents a fundamental resource in understanding the molecular pathways altered in FXS, physiological and evolutionary species-specific differences have hampered translating these results from rodents to humans, raising the need for a humanized FXS model. The gene discussed is FMR1; the disease is fragile X syndrome.